In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...
The 2024 AACR June L. Biedler Prize for Cancer Journalism winners were honored during the AACR Annual Meeting 2024.
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
The AACR Annual Meeting 2024 Opening Ceremony showcased impactful initiatives impacting cancer research.
A special issue of Cancer Discovery illustrates the vast landscape of research being explored within the AACR community.
The FDA issued 14 oncology approvals this quarter, including the first tumor-infiltrating lymphocyte therapy.
A few important details to help attendees get the most out of their experience at the AACR Annual Meeting...
AACRoC in Brazil let young investigators learn from cancer research experts during programs in São Paulo and Ribeirão Preto.
March's picks include how synergy drives drug resistance in AML, new early detection tools, and more.
Three patients share their experiences about having Lynch syndrome.
Researchers are exploring new options for kidney cancer treatments.